Adaptive Biotechnologies Corp

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Adaptive Biotechnologies Corp had 169.87M in cash and cash equivalents.

Adaptive Biotechnologies Corp reported 287.74M in total liabilities as of the latest reported quarter, including 89.92M in current liabilities and 197.82M in non-current liabilities.

As of the latest reported quarter, Adaptive Biotechnologies Corp's total assets were 512.74M, consisting of 300.19M in current assets and 212.55M in non-current assets.

Adaptive Biotechnologies Corp reported 225.00M in total shareholders' equity as of the latest reported quarter.